<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2023.461</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-1820</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Treatment and rehabilitation for cervical cancer: the experience of patient journey management</article-title><trans-title-group xml:lang="ru"><trans-title>Лечение и реабилитация при раке шейки матки: опыт организации маршрутизации пациентов</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-2166-2574</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акавова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Akavova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Акавова Саида Абдулкадыровна – врач-онколог, зав. Центром амбулаторной поликлинической помощи</p><p>117152 Москва, Загородное шоссе, д. 18А, стр. 7</p></bio><bio xml:lang="en"><p>Saida A. Akavova – MD, Oncologist, Head of Outpatient Care Cente</p><p>18A bldg. 7, Zagorodnoe Shosse, Moscow 117152</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7456-2386</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солопова</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Solopova</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Солопова Антонина Григорьевна – д.м.н., профессор кафедры акушерства, гинекологии и перинатальной медицины Клинического института детского здоровья имени Н.Ф. Филатова</p><p>119991 Москва, ул. Большая Пироговская, д. 2, стр. 4</p><p>Scopus Author ID: 6505479504</p><p>Researcher ID: Q-1385-2015</p></bio><bio xml:lang="en"><p>Antonina G. Solopova – MD, Dr Sci Med, Professor, Department of Obstetrics, Gynecology and Perinatal Medicine, Filatov Clinical Institute of Children’s Health</p><p>2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3367-9844</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинов</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Блинов Дмитрий Владиславович – к.м.н., ассистент кафедры спортивной медицины и медицинской реабилитации Института клинической медицины имени Н.В. Склифосовского; руководитель по медицинским и научным вопросам; доцент кафедрыспортивной, физической и реабилитационной медицины</p><p>119991 Москва, ул. Большая Пироговская, д. 2, стр. 4</p><p>127006 Москва, ул. Садовая-Триумфальная, д. 4–10</p><p>123056 Москва, 2-я Брестская ул., д. 5, с. 1–1а</p><p>Scopus Author ID: 6701744871</p><p>Researcher ID: E-8906-2017</p><p>RSCI: 9779-8290</p></bio><bio xml:lang="en"><p>Dmitry V. Blinov – MD, PhD, MBA, Assistant, Department of Sports Medicine and Medical Rehabilitation, Sklifosovsky Institute of Clinical Medicine, Sechenov University; Head of Medical and Scientific Affairs, Institute for Preventive and Social Medicine; Associate Professor, Department of Sports, Physical and Rehabilitation Medicine, Moscow Haass Medical – Social Institute</p><p>Scopus Author ID: 6701744871Researcher ID: E-8906-2017RSCI: 9779-8290</p><p>2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 1199914–10 Sadovaya-Triumfalnaya Str., Moscow 1270065 bldg. 1–1a, 2-ya Brestskaya Str., Moscow 123056</p></bio><email xlink:type="simple">blinov2010@googlemail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9964-5199</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ачкасов</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Achkasov</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ачкасов Евгений Евгеньевич – д.м.н., профессор, зав. кафедрой спортивной медицины и медицинской реабилитации Института клинической медицины имени Н.В. Склифосовского, директор Клиники медицинской реабилитации</p><p>119991 Москва, ул. Большая Пироговская, д. 2, стр. 4</p></bio><bio xml:lang="en"><p>Evgeniy E. Achkasov – MD, Dr Sci Med, Professor, Head of the Department of Sports Medicine and Rehabilitation, Sklifosovsky Institute of Clinical Medicine, Director of the Clinic for Medical Rehabilitation</p><p>2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6619-6179</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галкин</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Galkin</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галкин Всеволод Николаевич – д.м.н., профессор, главный врач</p><p>117152 Москва, Загородное шоссе, д. 18А, стр. 7</p></bio><bio xml:lang="en"><p>Vsevolod N. Galkin – MD, Dr Sci Med, Professor, Chief Physician</p><p>18A bldg. 7, Zagorodnoe Shosse, Moscow 11715</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0459-0488</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корабельников</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Korabelnikov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корабельников Даниил Иванович – к.м.н., профессор кафедры внутренних болезней с курсами семейной медицины, функциональной диагностики, инфекционных болезней, ректор</p><p>123056 Москва, 2-я Брестская ул., д. 5, с. 1–1а</p></bio><bio xml:lang="en"><p>Daniil I. Korabelnikov – MD, PhD, Professor, Department of Internal Medicine with Courses in Family Medicine, Functional Diagnostics, Infectious Diseases, Rector</p><p>5 bldg. 1–1a, 2-ya Brestskaya Str., Moscow 123056</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мнацаканьян</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Mnatsakanyan</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мнацаканьян Анна Никитична – к.ф.н., доцент кафедры Л2</p><p>105005 Москва, 2-я Бауманская ул., д. 5, стр. 1</p></bio><bio xml:lang="en"><p>Anna N. Mnatsakanyan – MD, PhD, Associate Professor, L2 Department</p><p>5 bldg. 1, 2-ya Baumanskaya Str., Moscow 105005</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5849-5585</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петренко</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrenko</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петренко Дарья Андреевна – клинический ординатор кафедры клинической фармакологии и пропедевтики внутренних болезней</p><p>119991 Москва, ул. Большая Пироговская, д. 2, стр. 4</p></bio><bio xml:lang="en"><p>Daria A. Petrenko – MD, Clinical Resident, Department of Clinical Pharmacology and Propaedeutics of Internal Diseases</p><p>2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быковщенко</surname><given-names>Г. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bykovshchenko</surname><given-names>G. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Быковщенко Георгий Константинович – студент 6-го курса</p><p>119991 Москва, ул. Большая Пироговская, д. 2, стр. 4</p></bio><bio xml:lang="en"><p>Georgy K. Bykovshchenko – 6th year Student</p><p>2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хазан</surname><given-names>П. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Khazan</surname><given-names>P. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хазан Петр Леонидович – к.м.н., врач-уролог, клинический фармаколог, старший научный сотрудник группы воспалительных заболеваний и клинической фармакологии</p><p> 105425 Москва, 3-я Парковая ул., д. 51, стр. 1 </p></bio><bio xml:lang="en"><p>Peter L. Khazan – MD, PhD, Urologist, Clinical Pharmacologist, Senior Researcher, Group of Inflammatory Diseases and Clinical Pharmacology</p><p>51 bldg. 1, 3-ya Parkovaya Str., Moscow 105425</p></bio><xref ref-type="aff" rid="aff-6"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Городская клиническая онкологическая больница № 1 Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Clinical Oncological Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет); Институт Превентивной и Социальной Медицины; АНО ДПО «Московский&#13;
медико-социальный институт имени Ф.П. Гааза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University; Institute for Preventive and Social Medicine; Moscow Haass Medical – Social Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>АНО ДПО «Московский медико-социальный институт имени Ф.П. Гааза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Haass Medical – Social Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГБУ ВО «Московский государственный технический университет имени Н.Э. Баумана (национальный исследовательский университет)»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bauman Moscow State Technical University (National Research University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Научно-исследовательский институт урологии и интервенционной радиологии имени Н.А. Лопаткина – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lopatkin Research Institute of Urology and Interventional Radiology – Branch of National Medical Research Radiological Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>11</month><year>2023</year></pub-date><volume>17</volume><issue>5</issue><fpage>625</fpage><lpage>637</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Akavova A.A., Solopova A.G., Blinov D.V., Achkasov E.E., Galkin V.N., Korabelnikov D.I., Mnatsakanyan A.N., Petrenko D.A., Bykovshchenko G.K., Khazan P.L., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Акавова С.А., Солопова А.Г., Блинов Д.В., Ачкасов Е.Е., Галкин В.Н., Корабельников Д.И., Мнацаканьян А.Н., Петренко Д.А., Быковщенко Г.К., Хазан П.Л.</copyright-holder><copyright-holder xml:lang="en">Akavova A.A., Solopova A.G., Blinov D.V., Achkasov E.E., Galkin V.N., Korabelnikov D.I., Mnatsakanyan A.N., Petrenko D.A., Bykovshchenko G.K., Khazan P.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/1820">https://www.gynecology.su/jour/article/view/1820</self-uri><abstract><p>Radical surgical intervention, chemoradiotherapy and immune therapy implicated for patients with cervical cancer (CC) can result in significant morphofunctional, psychological, sexual disorders and social maladjustment. To optimize treatment and rehabilitation for CC patients, a routing approach has been established. This approach involves the patient's journey during diagnosis and treatment with well-defined timed stages. Additionally, a rehabilitation program with lifelong follow-up has been implemented. Prior to commencing therapy, undertaking rehabilitation after oncogynecological treatment during the stage spanning from diagnosis to therapy initiation contributes to enhancing the quality of life (QoL) for CC patients.</p></abstract><trans-abstract xml:lang="ru"><p>Радикальное хирургическое вмешательство, химиолучевая, иммунная терапия у пациенток с раком шейки матки (РШМ) приводят к тяжелым морфофункциональным, психологическим, сексуальным расстройствам и социальной дезадаптации. С целью оптимизации лечения и последующей реабилитации пациенток с РШМ разработан подход к маршрутизации, включающий путь пациента на этапе диагностики и лечения с четко регламентированными по времени этапами, а также программа реабилитации с дальнейшим пожизненным диспансерным наблюдением. Пререабилитация на этапе от постановки диагноза до начала терапии, реабилитация после онкогинекологического лечения способствуют повышению качества жизни (КЖ) данной когорты больных.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>РШМ</kwd><kwd>лечение</kwd><kwd>качество жизни</kwd><kwd>КЖ</kwd><kwd>реабилитация</kwd><kwd>маршрутизация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cervical cancer</kwd><kwd>CC</kwd><kwd>treatment</kwd><kwd>quality of life</kwd><kwd>QoL</kwd><kwd>patient journey</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation><mixed-citation xml:lang="en">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cостояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ имени П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 239 с. Режим доступа: https://oncologyassociation.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskojpomoshhi-naseleniyu-rossii-v-2021-godu.pdf. [Дата обращения: 25.08.2023].</mixed-citation><mixed-citation xml:lang="en">The state of oncological care for the Russian population in 2021. Eds. A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. [Costoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj]. Moscow: Hertsen Moscow Oncology Research Institute – Branch of National Medical Research Radiological Centre, 2022. 239 p. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskoj-pomoshhinaseleniyu-rossii-v-2021-godu.pdf. [Accessed: 25.08.2023].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Европейский портал информации здравоохранения. Заболеваемость раком шейки матки. Режим доступа: https://gateway.euro.who.int/ru/indicators/hfa_377-2360-incidence-of-cervix-uteri-cancer-per-100-000/?id=19308&amp;fullGraph=true. [Дата обращения: 25.08.2023].</mixed-citation><mixed-citation xml:lang="en">European Health Information Portal. Incidence of cervical cancer. [Evropejskij portal informacii zdravoohraneniya. Zabolevaemost' rakom shejki matki]. (In Russ.). Available at: https://gateway.euro.who.int/ru/ indicators/hfa_377-2360-incidence-of-cervix-uteri-cancer-per-100-000/?id=19308&amp;fullGraph=true. [Accessed: 25.08.2023].</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Рак шейки матки. М.: Министерство здравоохранения Российской Федерации, 2020. 66 c. Режим доступа: https://oncology-association.ru/wp-content/uploads/2020/09/rak_shejki_ matki.pdf. [Дата обращения: 25.08.2023].</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines. Cervical cancer. [Klinicheskie rekomendacii. Rak shejki matki]. Мoscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2020. 66 p. (In Russ.). Available at: https://oncology-association.ru/ wp-content/uploads/2020/09/rak_shejki_matki.pdf. [Accessed: 25.08.2023].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Хохлова С.В., Коломиец Л.А., Кравец О.А. и др. Практические рекомендации по лекарственному лечению рака шейки матки. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2021;11:197–217. https://doi.org/10.18027/2224-5057-2021-11-3s2-13.</mixed-citation><mixed-citation xml:lang="en">Khokhlova S.V., Kolomiets L.A., Kravets O.A. et al. Practical recommendations for drug treatment of cervical cancer. Malignant tumors: Practical recommendations RUSSCO #3s2. [Prakticheskie rekomendacii po lekarstvennomu lecheniyu raka shejki matki. Zlokachestvennye opuholi: Prakticheskie rekomendacii RUSSCO #3s2]. 2021;11:197–217. (In Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-13.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Smith E.S., Moon A.S., O'Hanlon R. et al. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020;136(3):533–42. https://doi.org/10.1097/AOG.0000000000003952.</mixed-citation><mixed-citation xml:lang="en">Smith E.S., Moon A.S., O'Hanlon R. et al. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020;136(3):533–42. https://doi.org/10.1097/AOG.0000000000003952.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznicki M.L., Chambers L.M., Morton M. et al. Fertility-sparing surgery for early-stage cervical cancer: a systematic review of the literature. J Minim Invasive Gynecol. 2021;28(3):513–526.e1. https://doi.org/10.1016/j.jmig.2020.10.013.</mixed-citation><mixed-citation xml:lang="en">Kuznicki M.L., Chambers L.M., Morton M. et al. Fertility-sparing surgery for early-stage cervical cancer: a systematic review of the literature. J Minim Invasive Gynecol. 2021;28(3):513–526.e1. https://doi.org/10.1016/j.jmig.2020.10.013.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Okugawa K., Yahata H., Ohgami T. et al. An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis. J Gynecol Oncol. 2023;34(3):e41. https://doi.org/10.3802/jgo.2023.34.e41.</mixed-citation><mixed-citation xml:lang="en">Okugawa K., Yahata H., Ohgami T. et al. An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis. J Gynecol Oncol. 2023;34(3):e41. https://doi.org/10.3802/jgo.2023.34.e41.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatla N., Tomar S., Meena J. et al. Adjuvant treatment in cervical, vaginal and vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2022;78:36–51. https://doi.org/10.1016/j.bpobgyn.2021.07.005.</mixed-citation><mixed-citation xml:lang="en">Bhatla N., Tomar S., Meena J. et al. Adjuvant treatment in cervical, vaginal and vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2022;78:36–51. https://doi.org/10.1016/j.bpobgyn.2021.07.005.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dyer B.A., Feng C.H., Eskander R. et al. Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation. Int J Radiat Oncol Biol Phys. 2021;109(2):396–412. https://doi.org/10.1016/j.ijrobp.2020.09.016.</mixed-citation><mixed-citation xml:lang="en">Dyer B.A., Feng C.H., Eskander R. et al. Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation. Int J Radiat Oncol Biol Phys. 2021;109(2):396–412. https://doi.org/10.1016/j.ijrobp.2020.09.016.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rubinstein M.M., Makker V. Optimizing immunotherapy for gynecologic cancers. Curr Opin Obstet Gynecol. 2020;32(1):1–8. https://doi.org/10.1097/GCO.0000000000000603.</mixed-citation><mixed-citation xml:lang="en">Rubinstein M.M., Makker V. Optimizing immunotherapy for gynecologic cancers. Curr Opin Obstet Gynecol. 2020;32(1):1–8. https://doi.org/10.1097/GCO.0000000000000603.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Corte L.D., Barra F., Foreste V. et al. Advances in paclitaxel combinations for treating cervical cancer. Expert Opin Pharmacother. 2020;21(6):663– 77. https://doi.org/10.1080/14656566.2020.1724284.</mixed-citation><mixed-citation xml:lang="en">Corte L.D., Barra F., Foreste V. et al. Advances in paclitaxel combinations for treating cervical cancer. Expert Opin Pharmacother. 2020;21(6):663– 77. https://doi.org/10.1080/14656566.2020.1724284.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tewari K.S., Sill M.W., Long H.J. et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370(8):734–43. https://doi.org/10.1056/NEJMoa1309748.</mixed-citation><mixed-citation xml:lang="en">Tewari K.S., Sill M.W., Long H.J. et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370(8):734–43. https://doi.org/10.1056/NEJMoa1309748.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Блинов Д.В., Солопова А.Г., Плутницкий А.Н. и др. Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022;15(1):119–30. https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.</mixed-citation><mixed-citation xml:lang="en">Blinov D.V., Solopova A.G., Plutnitskiy A.N. et al. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. [Organizaciya zdravoohraneniya v sfere reabilitacii pacientok s onkologicheskimi zabolevaniyami reproduktivnoj sistemy]. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(1):119–30. (In Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Seland M., Skrede K., Lindemann K. et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022;101(3):313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation><mixed-citation xml:lang="en">Seland M., Skrede K., Lindemann K. et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022;101(3):313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol. 2015;58(3):476–91. https://doi.org/10.1097/GRF.0000000000000126.</mixed-citation><mixed-citation xml:lang="en">Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol. 2015;58(3):476–91. https://doi.org/10.1097/GRF.0000000000000126.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Nappi R.E., Palacios S., Panay N. et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2019;19(2):188–97. https://doi.org/10.3109/13697137.2015.1107039.</mixed-citation><mixed-citation xml:lang="en">Nappi R.E., Palacios S., Panay N. et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2019;19(2):188–97. https://doi.org/10.3109/13697137.2015.1107039.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Krychman M., Graham S., Bernick B. et al. The women's EMPOWER survey: women's knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–33. https://doi.org/10.1016/j.jsxm.2017.01.011.</mixed-citation><mixed-citation xml:lang="en">Krychman M., Graham S., Bernick B. et al. The women's EMPOWER survey: women's knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–33. https://doi.org/10.1016/j.jsxm.2017.01.011.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Ju X., Feng Z. et al. Progressive resistance exercise training to prevent lower-limb lymphedema after cervical cancer surgery: a feasibility study. Asia Pac J Oncol Nurs. 2021;9(1):32–8. https://doi.org/10.1016/j.apjon.2021.12.002.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Ju X., Feng Z. et al. Progressive resistance exercise training to prevent lower-limb lymphedema after cervical cancer surgery: a feasibility study. Asia Pac J Oncol Nurs. 2021;9(1):32–8. https://doi.org/10.1016/j.apjon.2021.12.002.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Pieterse Q.D., Kenter G.G., Maas C.P. et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23(9):1717–25. https://doi.org/10.1097/IGC.0b013e3182a80a65.</mixed-citation><mixed-citation xml:lang="en">Pieterse Q.D., Kenter G.G., Maas C.P. et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23(9):1717–25. https://doi.org/10.1097/IGC.0b013e3182a80a65.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bona A.F., Ferreira K.R., de Moura Carvalho R.B. et al. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697–704. https://doi.org/10.1136/ijgc-2020-001682.</mixed-citation><mixed-citation xml:lang="en">Bona A.F., Ferreira K.R., de Moura Carvalho R.B. et al. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697–704. https://doi.org/10.1136/ijgc-2020-001682.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hu H., Fu M., Huang X. et al. Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis. Transl Cancer Res. 2022;11(6):1713–21. https://doi.org/10.21037/tcr-22-1256.</mixed-citation><mixed-citation xml:lang="en">Hu H., Fu M., Huang X. et al. Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis. Transl Cancer Res. 2022;11(6):1713–21. https://doi.org/10.21037/tcr-22- 1256.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Сычева И.В. Лучевые повреждения органов малого таза у онкогинекологических больных и их лечение. Cвидетельство о регистрации базы данных RU RU2020620609, 27.03.2020. Заявка №2020620908 от 19.06.2020. Программы ЭВМ. Базы данных. Топологии интегральных микросхем. М.: Федеральный институт промышленной собственности. 2020;(4):99–105.</mixed-citation><mixed-citation xml:lang="en">Sycheva I.V. Radiation injuries of the pelvic organs in oncogynecological patients and their treatment. Certificate of registration of the database RU RU2020620609, 27.03.2020. Application No. 2020620908 dated of 19.06.2020. Computer programs. Databases. Topologies of integrated circuits. [Luchevye povrezhdeniya organov malogo taza u onkoginekologicheskih bol'nyh i ih lechenie. Cvidetel'stvo o registracii bazy dannyh RU RU2020620609, 27.03.2020. Zayavka №2020620908 ot 19.06.2020. Programmy EVM. Bazy dannyh. Topologii integral'nyh mikroskhem]. Moscow: Federal'nyj institut promyshlennoj sobstvennosti. 2020;(4):99–105. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Fawaz Z.S., Barkati M., Beauchemin M.C. et al. Cervical necrosis after chemoradiation for cervical cancer: case series and literature review. Radiat Oncol. 2013;8:220. https://doi.org/10.1186/1748-717X-8-220.</mixed-citation><mixed-citation xml:lang="en">Fawaz Z.S., Barkati M., Beauchemin M.C. et al. Cervical necrosis after chemoradiation for cervical cancer: case series and literature review. Radiat Oncol. 2013;8:220. https://doi.org/10.1186/1748-717X-8-220.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kirchheiner K., Fidarova E., Nout R.A. et al. Radiation-induced morphological changes in the vagina. Strahlenther Onkol. 2012;188(11):1010–7. https://doi.org/10.1007/s00066-012-0222-0.</mixed-citation><mixed-citation xml:lang="en">Kirchheiner K., Fidarova E., Nout R.A. et al. Radiation-induced morphological changes in the vagina. Strahlenther Onkol. 2012;188(11):1010–7. https://doi.org/10.1007/s00066-012-0222-0.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Leiper K., Morris A.I. Treatment of radiation proctitis. Clin Oncol (R Coll Radiol). 2007;19(9):724–9. https://doi.org/10.1016/j.clon.2007.07.008.</mixed-citation><mixed-citation xml:lang="en">Leiper K., Morris A.I. Treatment of radiation proctitis. Clin Oncol (R Coll Radiol). 2007;19(9):724–9. https://doi.org/10.1016/j.clon.2007.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Barker C.L., Routledge J.A., Farnell D.J. et al. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer. 2009;100(10):1558–65. https://doi.org/10.1038/sj.bjc.6605050.</mixed-citation><mixed-citation xml:lang="en">Barker C.L., Routledge J.A., Farnell D.J. et al. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer. 2009;100(10):1558–65. https://doi.org/10.1038/sj.bjc.6605050.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ji J., Zhu H., Zhao J.Z. et al. Negative emotions and their management in Chinese convalescent cervical cancer patients: a qualitative study. J Int Med Res. 2020;48(9):300060520948758. https://doi.org/10.1177/0300060520948758.</mixed-citation><mixed-citation xml:lang="en">Ji J., Zhu H., Zhao J.Z. et al. Negative emotions and their management in Chinese convalescent cervical cancer patients: a qualitative study. J Int Med Res. 2020;48(9):300060520948758. https://doi.org/10.1177/0300060520948758.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mantegna G., Petrillo M., Fuoco G. et al. Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis. BMC Cancer. 2013;13:127. https://doi.org/10.1186/1471-2407-13-127.</mixed-citation><mixed-citation xml:lang="en">Mantegna G., Petrillo M., Fuoco G. et al. Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis. BMC Cancer. 2013;13:127. https://doi.org/10.1186/1471-2407-13-127.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Park S.Y., Bae D.S., Nam J.H. et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716–25. https://doi.org/10.1002/cncr.23094.</mixed-citation><mixed-citation xml:lang="en">Park S.Y., Bae D.S., Nam J.H. et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716–25. https://doi.org/10.1002/cncr.23094.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bjelic-Radisic V., Jensen P.T., Vlasic K.K. et al. Quality of life characteristics inpatients with cervical cancer. Eur J Cancer. 2012;48(16):3009–18. https://doi.org/10.1016/j.ejca.2012.05.011.</mixed-citation><mixed-citation xml:lang="en">Bjelic-Radisic V., Jensen P.T., Vlasic K.K. et al. Quality of life characteristics inpatients with cervical cancer. Eur J Cancer. 2012;48(16):3009–18. https://doi.org/10.1016/j.ejca.2012.05.011.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Froeding L.P., Ottosen C., Rung-Hansen H. et al. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study. J Sex Med. 2014;11(2):595–604. https://doi.org/10.1111/jsm.12399.</mixed-citation><mixed-citation xml:lang="en">Froeding L.P., Ottosen C., Rung-Hansen H. et al. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study. J Sex Med. 2014;11(2):595–604. https://doi.org/10.1111/jsm.12399.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wiegel M., Meston C., Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20. https://doi.org/10.1080/00926230590475206.</mixed-citation><mixed-citation xml:lang="en">Wiegel M., Meston C., Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20. https://doi.org/10.1080/00926230590475206.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z., Shi H. Prognostic role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis. Dis Markers. 2019;2019:6710352. https://doi.org/10.1155/2019/6710352.</mixed-citation><mixed-citation xml:lang="en">Liu Z., Shi H. Prognostic role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis. Dis Markers. 2019;2019:6710352. https://doi.org/10.1155/2019/6710352.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Прилепская В.Н. ВПЧ-ассоциированные заболевания шейки матки: скрининг, методы обследования, принципы лечения. Гинекология. 2019;21(3):6–8. https://doi.org/10.26442/20795696.2019.3.190595.</mixed-citation><mixed-citation xml:lang="en">Prilepskaya V.N. HPV-associated cervical diseases: screening, methods of examination, principles of treatment. [VPCh-associirovannye zabolevaniya shejki matki: skrining, metody obsledovaniya, principy lecheniya]. Ginekologiya. 2019;21(3):6–8. (In Russ.). https://doi.org/10.26442/20795 696.2019.3.190595.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Бегович Ё., Солопова А.Г., Хлопкова С.В. и др. Возможности и перспективы эпигенетической реабилитации у пациенток с наружной формой генитального эндометриоза. Врач. 2022;33(5):5–8. https://doi.org/10.29296/25877305-2022-05-01.</mixed-citation><mixed-citation xml:lang="en">Begovich E., Solopova A.G., Khlopkova S.V. et al. Possibilities and prospects for epigenetic rehabilitation in patients with external form of genital endometriosis. [Vozmozhnosti i perspektivy epigeneticheskoj reabilitacii u pacientok s naruzhnoj formoj genital'nogo endometrioza]. Vrach. 2022;33(5):5–8. (In Russ.). https://doi.org/10.29296/25877305- 2022-05-01.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Власина А.Ю., Солопова А.Г., Иванова Е.А., Блбулян Т.А. «Противораковая диета», или принципы рационального питания онкогинекологических больных в период реабилитации. Врач. 2020;31(4):3–7. https://doi.org/10.29296/25877305-2020-04-01.</mixed-citation><mixed-citation xml:lang="en">Vlasina A.Yu., Solopova A.G., Ivanova E.A., Blbulyan T.A. Anticancer diet, or the principles of rational nutrition in gynecological cancer patients duringe rehabilitation. [«Protivorakovaya dieta», ili principy racional'nogo pitaniya onkoginekologicheskih bol'nyh v period reabilitacii]. Vrach. 2020;31(4):3– 7. (In Russ.). https://doi.org/10.29296/25877305-2020-04-01.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Liu L., He J. et al. Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its selfefficacy in postoperative patients with cervical cancer. Front Oncol. 2023;13:1118794. https://doi.org/10.3389/fonc.2023.1118794.</mixed-citation><mixed-citation xml:lang="en">Li X., Liu L., He J. et al. Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its selfefficacy in postoperative patients with cervical cancer. Front Oncol. 2023;13:1118794. https://doi.org/10.3389/fonc.2023.1118794.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Zhou C.K., Song J et al. Curative efficacy of low frequency electrical stimulation in preventing urinary retention after cervical cancer operation. World J Surg Oncol. 2019;17(1):141. https://doi.org/10.1186/s12957-019-1689-2.</mixed-citation><mixed-citation xml:lang="en">Li H., Zhou C.K., Song J et al. Curative efficacy of low frequency electrical stimulation in preventing urinary retention after cervical cancer operation. World J Surg Oncol. 2019;17(1):141. https://doi.org/10.1186/s12957-019-1689-2.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Cullen K., Fergus K., DasGupta T. et al. Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer. Support Care Cancer. 2013;21(7):1911–7. https://doi.org/10.1007/s00520-013-1726-6.</mixed-citation><mixed-citation xml:lang="en">Cullen K., Fergus K., DasGupta T. et al. Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer. Support Care Cancer. 2013;21(7):1911–7. https://doi.org/10.1007/s00520-013-1726-6.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Sacomori C., Araya-Castro P., Diaz-Guerrero P. et al. Pre-rehabilitation of the pelvic floor before radiation therapy for cervical cancer: a pilot study. Int Urogynecol J. 2020;31(11):2411–8. https://doi.org/10.1007/s00192-020-04391-5.</mixed-citation><mixed-citation xml:lang="en">Sacomori C., Araya-Castro P., Diaz-Guerrero P. et al. Pre-rehabilitation of the pelvic floor before radiation therapy for cervical cancer: a pilot study. Int Urogynecol J. 2020;31(11):2411–8. https://doi.org/10.1007/s00192-020-04391-5.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y.-C., Chang K.-V. Kegel Exercises. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2023.</mixed-citation><mixed-citation xml:lang="en">Huang Y.-C., Chang K.-V. Kegel Exercises. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2023.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Wu X., Liu Y., Zhu D. et al. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity lymphedema after operation of gynecologic cancer. Asian J Surg. 2021;44(1):111–5. https://doi.org/10.1016/j.asjsur.2020.03.022.</mixed-citation><mixed-citation xml:lang="en">Wu X., Liu Y., Zhu D. et al. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity ymphedema after operation of gynecologic cancer. Asian J Surg. 2021;44(1):111–5. https://doi.org/10.1016/j.asjsur.2020.03.022.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Cross D., Waheed N., Krake M., Gahreman D. Effectiveness of supervised Kegel exercises using bio-feedback versus unsupervised Kegel exercises on stress urinary incontinence: a quasi-experimental study. Int Urogynecol J. 2023;34(4):913–20. https://doi.org/10.1007/s00192-022-05281-8.</mixed-citation><mixed-citation xml:lang="en">Cross D., Waheed N., Krake M., Gahreman D. Effectiveness of supervised Kegel exercises using bio-feedback versus unsupervised Kegel exercises on stress urinary incontinence: a quasi-experimental study. Int Urogynecol J. 2023;34(4):913–20. https://doi.org/10.1007/s00192-022-05281-8.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Макацария А.Д., Блинов Д.В., Бицадзе В.О., Хизроева Д.Х. Лечение эстриолом вульвовагинальной атрофии в постменопаузе: обновление научных данных 2014–2018 гг. Акушерство, Гинекология и Репродукция. 2019;13(3):227–38. https://doi.org/10.17749/2313-7347.2019.13.227-238.</mixed-citation><mixed-citation xml:lang="en">Makatsariya A.D., Blinov D.V., Bitsadze V.O., Khizroeva J.K. Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018. [Lechenie estriolom vul'vovaginal'noj atrofii v postmenopauze: obnovlenie nauchnyh dannyh 2014–2018 gg.]. Obstetrics, Gynecology and Reproduction. 2019;13(3):227–38. (In Russ.). https://doi.org/10.17749/2313-7347.2019.13.3.227-238.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Y., Cai J., Wu Z. et al. Effects of a nurse-led positive psychology intervention on sexual function, depression and subjective well-being in postoperative patients with early-stage cervical cancer: A randomized controlled trial. Int J Nurs Stud. 2020;111:103768. https://doi.org/10.1016/j.ijnurstu.2020.103768.</mixed-citation><mixed-citation xml:lang="en">Shi Y., Cai J., Wu Z. et al. Effects of a nurse-led positive psychology intervention on sexual function, depression and subjective well-being in postoperative patients with early-stage cervical cancer: A randomized controlled trial. Int J Nurs Stud. 2020;111:103768. https://doi.org/10.1016/j.ijnurstu.2020.103768.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Блинов Д.В., Бегович Ё. и др. Неврологические расстройства после гистерэктомии: от патогенеза к клинике. Эпилепсия и пароксизмальные состояния. 2022;14(1):54–64. https://doi.org/10.17749/2077-8333/epi.par.con.2022.115.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Blinov D.V., Begovich E. et al. Neurological disorders after hysterectomy: from pathogenesis to clinical manifestations. [Nevrologicheskie rasstrojstva posle gisterektomii: ot patogeneza k klinike]. Epilepsy and paroxysmal conditions. 2022;14(1):54–64. (In Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2022.115.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Блинов Д.В., Демьянов С.В. и др. Эпигенетические аспекты реабилитации онкогинекологических больных. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022;15(2):294–303. https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.141.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Blinov D.V., Demyanov S.V. et al. Epigenetic aspects in rehabilitation of female cancer patients. [Epigeneticheskie aspekty reabilitacii onkoginekologicheskih bol'nyh]. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(2):294–303. (In Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.141.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
